Table 2.
Association of SNPs of candidate genes and odds ratio to PD risk.
| Candidate Gene | SNP | Model | p-valuea | ORa | 95% CIa | |
|---|---|---|---|---|---|---|
| PD vs. control | GALC | Rs8005172 | Allele model | 0.009 | 0.69 | (0.53, 0.92) |
| GALC | Rs8005172 | Additive modelc | 0.010 | – | – | |
| ZNF184 | rs9468199 | Allele model | 0.008 | 1.52 | (1.12, 2.08) | |
| ZNF184 | rs9468199 | Additive modelc | 0.008 | – | – | |
| IL1R2 | rs34043159 | Allele model | 0.034 | 1.31 | (1.02, 1.69) | |
| IL1R2 | rs34043159 | Additive modelc | 0.036 | – | – | |
| GALC | rs8005172 | Dominant model | 0.015 | 2.17 | (1.18, 4.15) | |
| GALC | rs8005172 | Dominant modelb | 0.020 | 2.11 | (1.14, 4.07) | |
| GALC | rs8005172 | Recessive modelb | 0.036 | 1.47 | (1.03, 2.12) | |
| ZNF184 | rs9468199 | Recessive model | 0.007 | 0.22 | (0.06, 0.60) | |
| ZNF184 | rs9468199 | Recessive modelb | 0.005 | 0.20 | (0.06, 0.56) | |
| LOPD vs. control | GALC | rs8005172 | Allele model | 0.016 | 0.71 | (0.53, 0.94) |
| GALC | rs8005172 | Additive modelc | 0.016 | – | – | |
| GALC | rs8005172 | Dominant model | 0.014 | 2.22 | (1.19, 4.29) | |
| GALC | rs8005172 | Dominant modelb | 0.011 | 2.39 | (1.23, 4.81) | |
| GALC | rs8005172 | Recessive modelb | 0.046 | 1.48 | (1.01, 2.18) | |
| EOPD vs. control | ELOVL7 | rs2694528 | Allele model | 0.032 | 2.24 | (1.05, 4.77) |
| ELOVL7 | rs2694528 | Additive modelc | 0.029 | – | – | |
| ZNF184 | rs9468199 | Allele model | 0.0001 | 2.82 | (1.62, 4.88) | |
| ZNF184 | rs9468199 | Additive modelc | 0.0001 | – | – | |
| ELOVL7 | rs2694528 | Dominant model | 0.024 | 2.60 | (1.10, 5.82) | |
| ZNF184 | rs9468199 | Dominant model | 0.024 | 2.34 | (1.12, 4.95) | |
| ZNF184 | rs9468199 | Recessive model | <0.0001 | 0.06 | (0.02, 0.23) | |
| ZNF184 | rs9468199 | Recessive modelb | 0.014 | 0.12 | (0.02, 0.62) | |
| ELOVL7 | rs2694528 | Overdominant model | 0.019 | 0.37 | (0.17, 0.88) | |
CI: Confidence Interval, EOPD: early onset Parkinson’s disease, LOPD: late onset Parkinson’s disease, OR: odd ratio, PD: Parkinson’s Disease; SNP: single nucleotide polymorphism.ap-value, OR and 95% CI were obtained from risk analysis and refer to the risk allele. bAdjusted for age and gender. cp-value was calculated by Cochran-Armitage trend test for additive model.